Pura Vida Investments’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-24,000
Closed -$4.59M 58
2024
Q2
$4.59M Sell
24,000
-4,000
-14% -$812K 2.91% 12
2024
Q1
$5.54M Buy
+28,000
New +$5.13M 0.93% 21
2023
Q4
Sell
-97,500
Closed -$14.4M 87
2023
Q3
$14.4M Buy
97,500
+62,400
+178% +$11.3M 2.73% 9
2023
Q2
$7.67M Sell
35,100
-14,900
-30% -$3.32M 1.02% 29
2023
Q1
$10.9M Buy
+50,000
New +$10.8M 1.11% 30
2022
Q2
Sell
-57,500
Closed -$13.9M 266
2022
Q1
$13.9M Buy
+57,500
New +$13.9M 0.45% 54
2016
Q1
Sell
-50,000
Closed -$2.69M 94
2015
Q4
$2.69M Buy
+50,000
New +$2.82M 1.13% 39

Other funds holding RMD

Pura Vida Investments's RMD Position: Q4 2022 in Review

Pura Vida Investments sold out of ResMed (RMD) in Q4 2022, closing a stake of 15,000 shares — an estimated $3.27M sold.

Pura Vida Investments first reported a position in RMD in Q4 2014 and held it in 2 quarters. The position peaked at $8.01M in Q4 2014. 732 funds tracked by Wall St. Rank hold RMD as of Q4 2022.

  • Pura Vida Investments reported no remaining ResMed position as of Q4 2022 after selling out during the quarter.
  • Pura Vida Investments sold 15,000 ResMed shares in Q4 2022, an estimated $3.27M.
  • Pura Vida Investments first reported a position in ResMed in Q4 2014 and held it in 2 quarters.
  • Pura Vida Investments's ResMed position peaked at $8.01M in Q4 2014.
  • 732 funds tracked by Wall St. Rank held ResMed as of Q4 2022.

Based on Pura Vida Investments's 13F filing for Q4 2022, filed 14 Feb 2023.